| Nome |
# |
|
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase, file eb99cc56-d170-4e04-9da3-fdf46797d63f
|
770
|
|
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, file e1dcb337-c798-7715-e053-1705fe0a6cc9
|
539
|
|
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, file e1dcb337-e6de-7715-e053-1705fe0a6cc9
|
519
|
|
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb338-737f-7715-e053-1705fe0a6cc9
|
423
|
|
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE?, file e1dcb336-78d5-7715-e053-1705fe0a6cc9
|
206
|
|
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems, file e1dcb339-e747-7715-e053-1705fe0a6cc9
|
173
|
|
ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance, file e1dcb33a-12f3-7715-e053-1705fe0a6cc9
|
139
|
|
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe., file e1dcb332-756f-7715-e053-1705fe0a6cc9
|
118
|
|
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance, file e1dcb338-b213-7715-e053-1705fe0a6cc9
|
114
|
|
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health, file e1dcb331-9448-7715-e053-1705fe0a6cc9
|
107
|
|
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study, file 7dce657a-d196-46b2-8baa-7482ac50b35b
|
104
|
|
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres, file e1dcb332-9652-7715-e053-1705fe0a6cc9
|
96
|
|
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature, file e1dcb331-d6bb-7715-e053-1705fe0a6cc9
|
92
|
|
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe, file e1dcb32d-4e3f-7715-e053-1705fe0a6cc9
|
78
|
|
Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas, file e1dcb334-f81b-7715-e053-1705fe0a6cc9
|
72
|
|
'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study', file e1dcb336-dc47-7715-e053-1705fe0a6cc9
|
66
|
|
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements, file e1dcb336-fb0d-7715-e053-1705fe0a6cc9
|
61
|
|
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit, file e1dcb32f-4c6b-7715-e053-1705fe0a6cc9
|
57
|
|
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies, file 42c8c724-e4be-4b4b-80d7-9e9049eb1e75
|
47
|
|
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb338-8430-7715-e053-1705fe0a6cc9
|
47
|
|
Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies, file a06b9444-daa6-4544-83b0-ba76f0d76428
|
46
|
|
Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough?, file e1dcb331-8ba1-7715-e053-1705fe0a6cc9
|
43
|
|
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance, file e1dcb336-bed1-7715-e053-1705fe0a6cc9
|
36
|
|
The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System, file 784c07f7-46ac-4a7d-bf08-9b5707e72415
|
34
|
|
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study, file d38ede64-ca6e-44d3-96d3-0eab14cb084c
|
32
|
|
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System, file eaca171a-ce1e-41f6-8a42-667f6cbdd357
|
29
|
|
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System, file c0101686-5837-4606-9b30-a38e2ac32429
|
25
|
|
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System, file e1dcb32e-178b-7715-e053-1705fe0a6cc9
|
25
|
|
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People, file 463640af-159b-41c1-b35f-8828f6a7a1f8
|
24
|
|
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region, file e1dcb339-d2a0-7715-e053-1705fe0a6cc9
|
24
|
|
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, file cf7d8fc4-5a7e-40a8-a176-6b5dab7929fe
|
23
|
|
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region, file 2f3b6736-cc5f-4d86-817b-d4a582642dbb
|
21
|
|
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System, file 4c1ab21e-4a86-468f-b565-8fdfefa93759
|
21
|
|
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials, file c1c104d0-a8ff-4958-b4fd-02ee623d15a2
|
21
|
|
Global prevalence of antidepressant utilization in the community: A protocol for a systematic review, file b13c0892-9f32-4bcd-b5fc-33e5d085b827
|
19
|
|
Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal, file 69f80cdd-a0a4-4c80-80bc-ab3e66a45bce
|
18
|
|
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe., file e1dcb332-7570-7715-e053-1705fe0a6cc9
|
18
|
|
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study, file e1dcb337-4310-7715-e053-1705fe0a6cc9
|
18
|
|
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe., file e1dcb332-7571-7715-e053-1705fe0a6cc9
|
16
|
|
Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System, file e1dcb339-4063-7715-e053-1705fe0a6cc9
|
16
|
|
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, file e1dcb339-4230-7715-e053-1705fe0a6cc9
|
15
|
|
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System, file e1dcb331-c79f-7715-e053-1705fe0a6cc9
|
13
|
|
Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology, file e1dcb339-8e22-7715-e053-1705fe0a6cc9
|
13
|
|
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, file 28c2f26d-ce73-4fb5-babf-66681de692e8
|
12
|
|
Medication Use and Costs Among Older Adults Aged 90 Years and Older in Italy, file 5a5ad938-b398-4f11-990e-7f21085aaa68
|
12
|
|
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database., file e1dcb32b-be51-7715-e053-1705fe0a6cc9
|
11
|
|
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry, file 7c410862-ff85-4949-8435-13e6f23a0bd6
|
10
|
|
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database, file e1dcb335-f680-7715-e053-1705fe0a6cc9
|
10
|
|
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis, file e1dcb336-c7d6-7715-e053-1705fe0a6cc9
|
10
|
|
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance, file e1dcb339-da19-7715-e053-1705fe0a6cc9
|
10
|
|
Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study, file 369b174c-3ebe-425d-84f8-372e94ab708d
|
9
|
|
Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study, file c623efb5-a4a6-47ff-92bd-1e1c4f664733
|
9
|
|
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions, file e1dcb336-73cc-7715-e053-1705fe0a6cc9
|
9
|
|
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, file e1dcb337-c79b-7715-e053-1705fe0a6cc9
|
9
|
|
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions, file 2f52c8e7-78d5-4925-861d-717e1395a63c
|
8
|
|
Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology, file 4c6bf437-ac77-4012-8cb0-d253ea4cab7a
|
8
|
|
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System, file b0a11f88-d7a2-4b48-a3ae-9841a77cd29c
|
8
|
|
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, file c0395b8a-a717-4186-aa67-37c2b908c849
|
8
|
|
SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?, file e1dcb336-ddb0-7715-e053-1705fe0a6cc9
|
8
|
|
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment, file 46fe2111-4d49-4e50-b12d-b45022612301
|
7
|
|
Global prevalence of antidepressant utilization in the community: A protocol for a systematic review, file 53409f97-32db-4375-902c-7158f2fb15df
|
7
|
|
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase, file 682d5bcd-e075-47cf-8b73-1681beb917b8
|
7
|
|
Medication use in Italian nursing homes: preliminary results from the national monitoring system, file 7dd3a68d-bc80-49cd-918a-7fc944769080
|
7
|
|
Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database, file d6a1690d-3e94-42d9-a26a-e8dcd9683974
|
7
|
|
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, file 7a76f612-27e6-4fff-b791-a1bf5aa6142b
|
6
|
|
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective, file e1dcb32c-ce26-7715-e053-1705fe0a6cc9
|
6
|
|
Global prevalence of antidepressant utilization in the community: A protocol for a systematic review, file 3b8eddf0-3dcb-4723-9e76-61c6ca2cd2b7
|
5
|
|
ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance, file bcddef07-ebab-4cd8-b04f-c6f4f5a76ef6
|
5
|
|
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry, file e1dcb338-5348-7715-e053-1705fe0a6cc9
|
5
|
|
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis, file 283fb261-c43d-4dd8-8c7a-5af22d135f22
|
4
|
|
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct, file 5f13a1ec-8185-4261-bfbe-fadc1cc55f64
|
4
|
|
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS, file 8f2af6e9-9a45-4b04-9df5-9ae0dc1c377d
|
4
|
|
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System, file 9872e675-f479-47c9-9867-28b38909c2aa
|
4
|
|
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database, file e1dcb32d-1c38-7715-e053-1705fe0a6cc9
|
4
|
|
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia, file e1dcb336-6202-7715-e053-1705fe0a6cc9
|
4
|
|
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems, file e1dcb33a-2f36-7715-e053-1705fe0a6cc9
|
4
|
|
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance, file 2f3b150d-32e4-4c62-81d7-061ed79cd9e0
|
3
|
|
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System, file 6123cec3-26d5-4009-92d8-fa4f5b109c33
|
3
|
|
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study, file 7b662054-0d67-4bd9-a369-d9a607f9600d
|
3
|
|
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection, file e1dcb32d-ed91-7715-e053-1705fe0a6cc9
|
3
|
|
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping, file e1dcb330-9165-7715-e053-1705fe0a6cc9
|
3
|
|
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb331-0899-7715-e053-1705fe0a6cc9
|
3
|
|
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors, file e1dcb335-55dd-7715-e053-1705fe0a6cc9
|
3
|
|
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems, file e1dcb33a-2f37-7715-e053-1705fe0a6cc9
|
3
|
|
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, file 1be23e9b-59ba-4baf-936b-bd717c99497f
|
2
|
|
Medication Use and Costs Among Older Adults Aged 90 Years and Older in Italy, file 2e3c39a7-d876-4dbc-9bf0-85bb0ef54b28
|
2
|
|
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach, file 864cab47-c7bb-4daa-af2a-434997e52301
|
2
|
|
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study, file cf50b922-16ec-4561-a01d-3672b9d1dd2f
|
2
|
|
Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database, file e1dcb32c-623f-7715-e053-1705fe0a6cc9
|
2
|
|
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey, file e1dcb32d-1c3d-7715-e053-1705fe0a6cc9
|
2
|
|
null, file e1dcb32d-dc84-7715-e053-1705fe0a6cc9
|
2
|
|
Stroke, Migraine and Triptans: From Bedside to Bench, file e1dcb32e-68fc-7715-e053-1705fe0a6cc9
|
2
|
|
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb331-089a-7715-e053-1705fe0a6cc9
|
2
|
|
Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety, file e1dcb333-f0af-7715-e053-1705fe0a6cc9
|
2
|
|
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb336-3681-7715-e053-1705fe0a6cc9
|
2
|
|
Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list, file e1dcb338-be9a-7715-e053-1705fe0a6cc9
|
2
|
|
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study, file 185cc669-d236-42f3-9712-502b2306e2b3
|
1
|
|
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct, file 1ad0bad2-969b-49a3-b81a-60cf351e6fa4
|
1
|
|
Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study, file 204ab1d1-8fce-4093-b095-f5a14da79d3d
|
1
|
|
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list?, file 39a3b588-aefd-4061-84bb-e55ba8464ef8
|
1
|
| Totale |
4.671 |